BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kang SW, Lim SH, Kim MJ, Lee J, Park YS, Lim HY, Kang WK, Kim ST. Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1. World J Gastrointest Oncol 2024; 16(8): 3521-3528 [PMID: 39171162 DOI: 10.4251/wjgo.v16.i8.3521]
URL: https://www.wjgnet.com/1948-5204/full/v16/i8/3521.htm
Number Citing Articles
1
Ghanshyam Biswas, Sumit Goyal, Amit Rauthan, Syed Mujtaba Hussain Naqvi, Sunil Kumar Yadav Yadagiri, Gauri Debashish Dhanaki, Arti Sanghavi, Rohit Kumar, Sagar Katare, Bhavesh P Kotak. Real-World Experience With Panitumumab or Bevacizumab as a First-Line Treatment for Metastatic Colorectal Cancer: An Indian PerspectiveCureus 2025;  doi: 10.7759/cureus.97914
2
Gang Wang, Zenyaran Yue, Fangyuan Chen, Cong Peng, Tingting Bi, Wen Zhou, Weiwei He, Xiying Tan, Xu Wang, Yuwei Zhang, Yong Bian, Gang Yin, Lifeng Zhu, Decai Tang. PLCγ1 in Curdione-Mediated Angiogenesis-EMT Interaction and Colorectal Cancer MetastasisPhytomedicine 2025; : 157753 doi: 10.1016/j.phymed.2025.157753
3
Yuan Qin, Fu-Yuan Ma, Zhi Zhang, Chen-Hao Zhao, Biao Huang. Vascular endothelial growth factor pathway’s influence on bevacizumab efficacy in metastatic colorectal cancer treatmentWorld Journal of Gastrointestinal Oncology 2024; 16(11): 4514-4517 doi: 10.4251/wjgo.v16.i11.4514